Predictive Oncology Inc. Annual Operating Income (Loss) in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Predictive Oncology Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2023.
  • Predictive Oncology Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$2.31M, a 15.5% increase year-over-year.
  • Predictive Oncology Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$13.7M, a 24.6% increase year-over-year.
  • Predictive Oncology Inc. annual Operating Income (Loss) for 2023 was -$14.1M, a 45.9% increase from 2022.
  • Predictive Oncology Inc. annual Operating Income (Loss) for 2022 was -$26M, a 27.4% decline from 2021.
  • Predictive Oncology Inc. annual Operating Income (Loss) for 2021 was -$20.4M, a 19.4% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$14.1M +$11.9M +45.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 -$26M -$5.61M -27.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 -$20.4M +$4.93M +19.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-21
2020 -$25.4M -$2.72M -12% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 -$22.6M -$14.8M -188% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-15
2018 -$7.86M Jan 1, 2018 Dec 31, 2018 10-K 2020-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.